|Articles|November 11, 2007
Highlights from Day 2 of the AAO Congress
New roles for the femtosecond discussed. Subretinal implant disappoints. Genentech defends its actions relating to Avastin decision. Glaucoma pipeline looks very healthy, and much more.
Advertisement
Newsletter
Advertisement
Latest CME
Advertisement
Advertisement











































